Bristol-Myers Squibb as of November 12, 2025 · AsOf
Viewing the record as of . Facts, events and changes are as the record holds them for that day. Back to today
organization
Bristol-Myers Squibb
As of , Bristol-Myers Squibb was an American pharmaceutical company, headquartered in Princeton. Its CEO was Christopher S. Boerner, Ph.D, since . It reported revenue of $48.30B for the period ended .
Models, products and related entities are not dated to , so they are left out here. They are on today’s record.
State as of
13 assertedThe record stands behind this value for the day asked: two independent sources agree, or a primary source states it (alone, at confidence 0.7 or more). Everything else stays on the record, labelled.More in About → facts
Bristol-Myers Squibb: state as of 2025-11-12, one row per fact with its value, date, confidence and sources
fact
value
valid fromThe day the value took effect, not the day it was published. A period figure (a year's revenue) is dated at the period's end.More in About →
confidenceHow well the sources support the value, from 0 to 1. A single primary source is asserted from 0.7; nothing below 0.5 is asserted; a dead or disagreeing source lowers it.More in About →
sourcesPrimary: the entity's own filing, feed or site. Secondary: a publisher reporting it. Each claim links every source it has, with the passage that states the value where one was read.More in About →
Filing and registry details2 claims · registrant name, legal form, listing, fiscal year
listed on
registrant name
Held, not asserted1 claimheld, not assertedOn the record but not the answer: one source without a primary, sources that disagree, confidence below the line, or a value marked for review. Kept and labelled until a source settles it.More in About →
As reported in the linked filings, which may be restated. Not investment advice.
State changes since
21 changes · supersededA later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.More in About →